![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Phase 2, Double-Blind, Randomized Study Comparing The Safety of Tenofovir Disoproxil Fumarate (TDF), Emtricitabine Plus TDF (Truvada, TVD) and Entecavir (ETV) in Subjects with Decompensated Chronic Hepatitis B Liver Disease
|
|
|
Reported by Jules Levin
AASLD Oct 31-Nov 2 2009, Boston, MA
Y-F Liaw1, C-M Lee2, U Akaraca3, G Papatheodoridis4, F Wong5, TT Chang6, A Horban7, C Wang8, P Kwan9, M Buti10, M Prieto11, T Berg12, K Kitrinos13, J Sorbel13, E Mondou13, D Frederick13, F Rousseau13, E Schiff14 Interim 48 Week Data
![image002.gif](../images/121109/image002.gif)
![image004.gif](../images/121109/image004.gif)
![image006.gif](../images/121109/image006.gif)
![image008.gif](../images/121109/image008.gif)
![image010.gif](../images/121109/image010.gif)
![image012.gif](../images/121109/image012.gif)
![image014.gif](../images/121109/image014.gif)
![image016.gif](../images/121109/image016.gif)
![image018.gif](../images/121109/image018.gif)
![image020.gif](../images/121109/image020.gif)
![image022.gif](../images/121109/image022.gif)
![image024.gif](../images/121109/image024.gif)
![image026.gif](../images/121109/image026.gif)
![image028.gif](../images/121109/image028.gif)
![image030.gif](../images/121109/image030.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|